Literature DB >> 21110136

Saikosaponins: a potential treatment option for systemic lupus erythematosus.

G-C Wu1, H Wu, L-Y Fan, H-F Pan.   

Abstract

While the exact cause of systemic lupus erythematosus (SLE) is still unknown, modern medicine has a number of effective treatments for this complex disorder. Corticosteroid hormones help reduce inflammation, antimalarial treatments address flare-ups and immunosuppressive medications work to keep the immune system in check. All these therapies are well tolerated, but accompany an increased risk of infection and nephrotoxicity. Recently, several studies showed that a number of natural and herbal products may also help some SLE patients deal with the debilitating symptoms. In this brief report, we proposed a traditional Chinese medicinal herb--Saikosaponins, and discussed its potential as a treatment option for SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110136     DOI: 10.1007/s11845-010-0646-4

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  22 in total

Review 1.  [Progress in research on antitumor activity of saikosaponin and its mechanism].

Authors:  Yan-Li Wang; Shui-Xiang He; Jin-Yan Luo
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2006-01

2.  Radix Astragali: a promising new treatment option for systemic lupus erythematosus.

Authors:  Hai Feng Pan; Xue Hui Fang; Wen Xian Li; Dong Qing Ye; Guo Cui Wu; Xiang Pei Li
Journal:  Med Hypotheses       Date:  2008-04-25       Impact factor: 1.538

Review 3.  The efficacy of herbal medicine--an overview.

Authors:  Edzard Ernst
Journal:  Fundam Clin Pharmacol       Date:  2005-08       Impact factor: 2.748

4.  Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor.

Authors:  Chung Yee Leung; Liang Liu; Ricky N S Wong; Yao Ying Zeng; Ming Li; Hua Zhou
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

5.  Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.

Authors:  Ping Li; Yuewen Gong; Ning Zu; Yajun Li; Bin Wang; Fujio Shimizu
Journal:  Nephron Exp Nephrol       Date:  2005-08-11

6.  Effects of saikosaponin-d on the functions and morphology of macrophages.

Authors:  Y Ushio; H Abe
Journal:  Int J Immunopharmacol       Date:  1991

Review 7.  Lupus nephritis.

Authors:  Neerja Agrawal; Lo-Ku Chiang; Ian R Rifkin
Journal:  Semin Nephrol       Date:  2006-03       Impact factor: 5.299

8.  Effect of saikosaponin derivatives upon the immune response against T-dependent and T-independent antigens in mice.

Authors:  N Yamaguchi; H Kohno; M Tawara; S Odashima; H Abe
Journal:  Int J Immunopharmacol       Date:  1985

9.  Anti-inflammatory activity of saikosaponins from Heteromorpha trifoliata.

Authors:  M C Recio; M J Just; R M Giner; S Mañez; J L Rios; K Hostettmann
Journal:  J Nat Prod       Date:  1995-01       Impact factor: 4.050

10.  In vivo and in vitro antiinflammatory activity of saikosaponins.

Authors:  P Bermejo Benito; M J Abad Martínez; A M Silván Sen; A Sanz Gómez; L Fernández Matellano; S Sánchez Contreras; A M Díaz Lanza
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

View more
  5 in total

1.  Anti-Inflammation Effects and Potential Mechanism of Saikosaponins by Regulating Nicotinate and Nicotinamide Metabolism and Arachidonic Acid Metabolism.

Authors:  Yu Ma; Yongrui Bao; Shuai Wang; Tianjiao Li; Xin Chang; Guanlin Yang; Xiansheng Meng
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

Review 2.  The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.

Authors:  Byeong Mo Kim
Journal:  Oxid Med Cell Longev       Date:  2018-04-12       Impact factor: 6.543

Review 3.  Systemic Lupus Erythematosus in Children and Young People.

Authors:  A Charras; E Smith; C M Hedrich
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

4.  Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells.

Authors:  Jie Zhu; Chengqun Luo; Ping Wang; Quanyong He; Jianda Zhou; Hao Peng
Journal:  Exp Ther Med       Date:  2013-03-04       Impact factor: 2.447

5.  Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells.

Authors:  Vincent Kam Wai Wong; Molly Miao Zhang; Hua Zhou; Kelly Yin Ching Lam; Po Ling Chan; Carmen Ka Man Law; Patrick Ying Kit Yue; Liang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-12       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.